...
首页> 外文期刊>The journal of maternal-fetal & neonatal medicine >The impact of intrauterine treatment on fetal tachycardia: a nationwide survey in Japan
【24h】

The impact of intrauterine treatment on fetal tachycardia: a nationwide survey in Japan

机译:宫内治疗对胎儿心动过缓的影响:日本全国范围

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To investigate the clinical course of fetal tachycardia and analyze the impact of intrauterine treatment on the postnatal treatment and patient outcomes. Study design: This was a retrospective review of cases of fetal tachycardia that occurred from 2004 to 2006. Data were collected from questionnaires that were sent to all 750 secondary or tertiary perinatal care centers in Japan. Results: Eighty-two cases (14 with fetal hydrops) were analyzed (supraventricular tachycardia [SVT], n - 52; atrial flutter [AFL], n - 23; and ventricular tachycardia, n - 7). The overall mortality was 3.7%. Intrauterine treatment was performed for 41 fetuses (50.0%). Digoxin, flecainide and sotalol were mainly used for SVT and AFL. Fetal tachycardia resolved in 90.0% (27/30) of the cases without fetal hydrops and 90.9% (10/11) of the cases with fetal hydrops. Intrauterine treatment significantly reduced the incidence of cesarean delivery (29.3 vs. 70.7%, p<.01), preterm birth (12.2 vs. 41.5%, p = .02) and neonatal arrhythmias (48.8 vs. 78.0%, p = .01) in comparison to untreated fetuses.
机译:目的:探讨胎儿心动过速的临床进程,分析宫内治疗对产后治疗和患者结果的影响。研究设计:这是对2004年至2006年发生的胎儿心动过速病例的回顾性审查。从调查问卷收集数据,这些问题被送到了日本的所有750个中学或第三次围产期护理中心。结果:分析了八十二个病例(14例,胎儿水库)(Supraventriculary CarcarcaIs [SVT],N - 52;心房颤动[AFL],N - 23;和心室性心动过速,N - 7)。总体死亡率为3.7%。宫内处理用于41胎(50.0%)。地高辛,Flecainide和Sotalol主要用于SVT和AFL。胎儿心动过速在没有胎儿水中的90.0%(27/30)的情况下,90.9%(10/11)胎儿水水的病例。宫内治疗显着降低了循环递送的发病率(29.3〜70.7%,P <.01),早产(12.2与41.5%,P = .02)和新生儿心律失常(48.8与78.0%,P = .01 )与未经处理的胎儿相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号